Get the Stockscreener App
1.03
3.00%
0.03
After Hours:
2.58
1.55
+150.49%
Pharmacyte Biotech Inc stock is traded at $1.03, with a volume of 116.10K.
It is up +3.00% in the last 24 hours and down -0.96% over the past month.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
See More
Previous Close:
$1.00
Open:
$1.01
24h Volume:
116.10K
Relative Volume:
1.23
Market Cap:
$7.00M
Revenue:
-
Net Income/Loss:
$22.68M
P/E Ratio:
1.9434
EPS:
0.53
Net Cash Flow:
$-1.94M
1W Performance:
+1.98%
1M Performance:
-0.96%
6M Performance:
-14.17%
1Y Performance:
-40.46%
1-Day Range:
$0.97
$1.04
1-Week Range:
$0.9693
$1.05
52-Week Range:
$0.80
$2.4229
Pharmacyte Biotech Inc Stock (PMCB) Company Profile
Name
Pharmacyte Biotech Inc
Sector
Industry
Phone
(917) 595.2850
Address
3960 HOWARD HUGHES PARKWAY, LAS VEGAS
Compare PMCB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 2.24 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
4.07 | 5.67B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.22 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
3.13 | 109.81M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.195 | 429.79M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.08 | 0 | 0 | 0 | 0 | 0.00 |
Pharmacyte Biotech Inc Stock (PMCB) Latest News
What sentiment indicators say about PharmaCyte Biotech Inc. stockPortfolio Gains Summary & Technical Pattern Alert System - newser.com
What to do if you’re stuck in PharmaCyte Biotech Inc.Trade Analysis Summary & Safe Capital Allocation Plans - newser.com
What Fibonacci levels say about PharmaCyte Biotech Inc. reboundMarket Rally & Growth Oriented Trade Recommendations - newser.com
Will PharmaCyte Biotech Inc. stock recover after recent dropGap Down & Reliable Price Breakout Signals - newser.com
Will PharmaCyte Biotech Inc. stock benefit from sector rotation2025 Support & Resistance & Daily Risk Controlled Trade Plans - newser.com
Can PharmaCyte Biotech Inc. recover in the next quarterIndex Update & AI Driven Stock Movement Reports - newser.com
Can PharmaCyte Biotech Inc. stock hit record highs again2025 Trading Volume Trends & Daily Profit Maximizing Tips - newser.com
How to recover losses in PharmaCyte Biotech Inc. stockGlobal Markets & Weekly Momentum Stock Picks - newser.com
Should you wait for a breakout in PharmaCyte Biotech Inc.Market Performance Summary & Reliable Volume Spike Trade Alerts - newser.com
PharmaCyte Biotech Inc. stock prediction for this weekTake Profit & Weekly High Return Forecasts - newser.com
Is PharmaCyte Biotech Inc. stock bottoming out2025 Top Decliners & AI Forecasted Entry and Exit Points - newser.com
Regression analysis insights on PharmaCyte Biotech Inc. performanceQuarterly Earnings Report & Expert Approved Momentum Trade Ideas - newser.com
Intraday pattern recognizer results for PharmaCyte Biotech Inc.July 2025 Closing Moves & Free Community Supported Trade Ideas - newser.com
Smart tools for monitoring PharmaCyte Biotech Inc.’s price actionQuarterly Trade Review & Free Community Supported Trade Ideas - newser.com
Published on: 2025-10-05 03:26:23 - newser.com
Relative strength of PharmaCyte Biotech Inc. in sector analysis - newser.com
Published on: 2025-10-03 02:37:56 - newser.com
PharmaCyte Biotech Inc. recovery potential after sell offGap Up & Low Risk High Win Rate Stock Picks - newser.com
Will PharmaCyte Biotech Inc. stock return to pre crisis levelsJuly 2025 Movers & Verified Chart Pattern Trade Signals - newser.com
Is PharmaCyte Biotech Inc a good long term investmentBlue Chip Stock Analysis & Double Or Triple Investment - earlytimes.in
PharmaCyte Biotech (OTCMKTS:PMCBD) Stock Price Down 0.1% – Time to Sell? - Defense World
What drives PharmaCyte Biotech Inc stock priceInstitutional Buying Trends & AI-Driven Stock Forecast Models - earlytimes.in
Pharmacyte Biotech Inc Stock (PMCB) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.15%
1.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):